AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 124 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $423,000 | -79.7% | 22,000 | -68.8% | 0.01% | -79.4% |
| Q2 2019 | $2,083,000 | +3.6% | 70,484 | +66.6% | 0.07% | +4.6% |
| Q1 2019 | $2,010,000 | +134.5% | 42,313 | +78.3% | 0.06% | +116.7% |
| Q4 2018 | $857,000 | -39.5% | 23,735 | +3.2% | 0.03% | -28.6% |
| Q3 2018 | $1,416,000 | -8.8% | 23,001 | +0.1% | 0.04% | -8.7% |
| Q2 2018 | $1,552,000 | +20.0% | 22,969 | -3.6% | 0.05% | +4.5% |
| Q1 2018 | $1,293,000 | -10.4% | 23,837 | -1.3% | 0.04% | -10.2% |
| Q4 2017 | $1,443,000 | +16.1% | 24,158 | -5.6% | 0.05% | +16.7% |
| Q3 2017 | $1,243,000 | -4.6% | 25,591 | +3.2% | 0.04% | -14.3% |
| Q2 2017 | $1,303,000 | +15.9% | 24,800 | +0.0% | 0.05% | +19.5% |
| Q1 2017 | $1,124,000 | -24.2% | 24,790 | -36.7% | 0.04% | -19.6% |
| Q4 2016 | $1,482,000 | -63.2% | 39,165 | -63.3% | 0.05% | -29.2% |
| Q3 2016 | $4,027,000 | -63.7% | 106,715 | -69.9% | 0.07% | -66.7% |
| Q1 2015 | $11,096,000 | +105.6% | 354,045 | +91.5% | 0.22% | +91.2% |
| Q4 2014 | $5,397,000 | – | 184,905 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |